Bryan Richard Hinton - Oct 25, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Technology Officer
Signature: /s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Oct 25, 2021
Transactions value $: -$10,364
Form type: 4
Date filed: 10/27/2021, 05:01 PM
Previous filing: Oct 5, 2021
Next filing: Nov 8, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Options Exercise	$2.81K	+260	+1.39%	$10.80	19K	Oct 25, 2021	Direct
transaction	HCAT	Common Stock	Sale	-$13.2K	-260	-1.37%	$50.66	18.8K	Oct 25, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCAT	Stock Option (Right to Buy)	Options Exercise	$0	-260	-8.33%	$0.00	2.86K	Oct 25, 2021	Common Stock	260	$10.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
F2	25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.